title: Expression of human 8-oxoguanine DNA glycosylase (hOGG1) in follicular lymphoma.
abstract: The human homologue of the yeast DNA repair enzyme 8-oxoguanine DNA glycosylase (hOGG1) repairs oxidatively damaged guanosine nucleotides in DNA. This enzyme is highly expressed in reactive germinal centers, where lymphoid cells are under oxidative stress, and has been thought to protect lymphocytes from mutation. As a first step to investigate the role of hOGG1 in lymphomagenesis, we evaluated hOGG1 expression in follicular lymphoma. Immunohistochemistry was performed on formalin-fixed paraffin-embedded tissue of 28 follicular lymphoma cases (16 grade 1, seven grade 2, and five grade 3) to evaluate the expression of hOGG1 in neoplastic follicles. Reactive germinal centers of non-neoplastic tonsil and lymph node tissue were also examined. Fluorescent-in-situ hybridization (FISH) was performed using a DNA probe from BAC clone RP11-266J6 corresponding to 3p25, where the hOGG1 gene resides, to evaluate for the presence or absence of a deletion. In reactive germinal centers, the majority of centroblasts and centrocytes were positive for hOGG1. In contrast, the majority (21 of 28 or 75%) of follicular lymphoma cases showed absent/minimal expression of hOGG1. Only four of 28 (14%) follicular lymphoma cases revealed the same levels of hOGG1 expression as reactive germinal centers. There was no correlation between hOGG1 expression and histologic grade. None of the 16 cases evaluated by FISH showed a deletion of hOGG1. Furthermore, absent/minimal hOGG1 expression was observed in four of six Bcl-2-negative follicular lymphoma cases. Our findings suggest that absent/minimal hOGG1 expression occurs in the majority of follicular lymphomas. The downregulation of hOGG1 does not appear to be due to a deletion of the hOGG1 locus. Additionally, finding absent/minimal hOGG1 expression in a subset of Bcl-2-negative follicular lymphomas suggests that hOGG1 may have utility in diagnosing Bcl-2-negative follicular lymphomas.
authors.affiliation: Department of Pathology, Baylor College of Medicine, Houston, TX 77030, USA.
authors.forename: Andrea M
authors.initials: AM
authors.lastname: Sheehan
authors.forename: David K
authors.initials: DK
authors.lastname: McGregor
authors.forename: Ankita
authors.initials: A
authors.lastname: Patel
authors.forename: Vinod
authors.initials: V
authors.lastname: Shidham
authors.forename: Chung-Yang
authors.initials: CY
authors.lastname: Fan
authors.forename: Chung-Che
authors.initials: CC
authors.lastname: Chang
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D045647:DNA Glycosylases / Q000096:biosynthesis* / Q000235:genetics; D005260:Female; D018628:Gene Dosage; D018858:Germinal Center / Q000378:metabolism; D006801:Humans; D007150:Immunohistochemistry; D017404:In Situ Hybridization, Fluorescence; D008198:Lymph Nodes / Q000378:metabolism; D008224:Lymphoma, Follicular / Q000378:metabolism*; D008297:Male; D008875:Middle Aged; D014066:Palatine Tonsil / Q000378:metabolism; D019253:Proto-Oncogene Proteins c-bcl-2
chemical_list: D019253:Proto-Oncogene Proteins c-bcl-2; D045647:DNA Glycosylases; C479058:oxoguanine glycosylase 1, human